EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep learning‐based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife

Hilla Magga, Henri Korkalainen, Tuomas Virén, Janne Heikkilä, Jan Seppälä, Akseli Leino

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Hilla Magga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technical Physics, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Deep Learning, Radiosurgery, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deep learning‐based (DL) approaches have gained interest in predicting dose distributions in radiotherapy of prostate cancer treated with volumetric modulated arc therapy and intensity‐modulated radiation therapy. Meanwhile, research on predicting dose distributions in high‐precision stereotactic radiotherapy treatments has remained relatively underrepresented.

Purpose

We aimed to expand the previous studies by developing a DL‐based framework for predicting dose distributions for robotic, stereotactic prostate cancer radiotherapy.

Methods

We harnessed a U‐Net‐based convolutional neural network for predicting clinically achievable dose distributions based on CT images, delineated structures, and distance information from the planning target volume. A dataset of 462 patients treated with CyberKnife (Accuray Inc.) utilizing an Iris collimator was divided into training (70%, n = 323), validation (10%, n = 46), and test (20%, n = 93) sets.

Results

In the independent test set, the mean absolute error between the mean doses of predictions and clinical plans was 0.63 Gy for the rectum and 1.04 Gy for the bladder.

Conclusions

The proposed U‐Net‐based model demonstrated the ability to learn and reproduce characteristic dose distributions in CyberKnife prostate cancer radiotherapy. The model may provide patient‐specific dose estimates for setting initial planning objectives to assist in automating treatment planning and improving inter‐planner consistency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDeep LearningRadiosurgeryRadiotherapy Planning, Computer-AssistedHumansMaleRadiotherapy DosageRadiotherapy, Intensity-ModulatedOrgans at RiskConvolutional Neural NetworksTomography, X-Ray Computed

Stichwörter der Autor:innen

CyberKnifedeep learningdose predictionprostate cancerradiotherapy

Autor:innen und Institutionen

  • Department of Technical Physics, University of Eastern Finland, Kuopio, Finland.
  • Center of Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Department of Nuclear Medicine, Satasairaala Hospital, Pori, Finland.

Zitieren

APA

Magga, H., Korkalainen, H., Virén, T., Heikkilä, J., Seppälä, J., & Leino, A. (2026). Deep learning‐based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70784

Vancouver

Magga H, Korkalainen H, Virén T, Heikkilä J, Seppälä J, Leino A. Deep learning‐based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70784

BibTeX
@article{Magga2026,
  author = {Magga, Hilla and Korkalainen, Henri and Virén, Tuomas and Heikkilä, Janne and Seppälä, Jan and Leino, Akseli},
  title = {Deep learning‐based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70784}
}
Kostenlos starten →